Utilization of parenteral anti-infective agents in the medical emergency unit of a tertiary care hospital: An observational study

Pharmacoepidemiology and Drug Safety

Volumn 13, Issue 9, 2004, Pages 653-657

  Gupta, M ^a   Malhotra, Samir ^a   Chandra, K K ^a   Sharma, N ^a   Pandhi, P ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Drug utilization; Medical audit; Prescription

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; OFLOXACIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON; TEICOPLANIN; TIMENTIN; UNINDEXED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT; AGE; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; CONTROLLED STUDY; DATA ANALYSIS; DRUG COST; DRUG INDICATION; DRUG UTILIZATION; EMERGENCY WARD; FEMALE; GENDER; HEALTH CARE COST; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PHARMACY; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTI-INFECTIVE AGENTS; CHILD; DRUG UTILIZATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALS, TEACHING; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; SEX FACTORS;

EID: 4644372796     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.927     Document Type: Review

References (13)

1. Tognoni G, Liberati A, Pello L, Sasanelli F, Spagnoli A. Drug utilization studies and epidemiology. Rev Epidemiol 1983; 31: 59-71.
2. WHO Regional Publications. Studies in Drug Unilization. European Series No. 8. WHO Regional Publications: Copenhagen, 1979.
3. Malcolm C, Marrie TJ. Antibiotic therapy for ambulatory patients with community acquired pneumonia in an emergency department setting. Arch Int Med 2003; 163: 797-802.
4. Furnish statistics on Medicines, Alterations to ATC classification, valid as of January 2002. National Agency for Medicines and Social Insurance Institution Helsinki 2002. P.294.
5. Kunin CM, Johansen KS, Worning AM, Daschner FD. Report of a symposium of use and abuse of antibiotics. Worldwide Rev Inpect Dis 1990; 12: 12-19.
6. Atanasona E, Terzivanov D. Investigations on antibiotics in a hospital for a one year period. Int J Clin Pharm Ther 1995; 33: 32-33.
7. Bernstein JM. Treatment of community acquired pneumonia IDSA guidelines: infections disease society of America. Chest 1999; 115 (Suppl.): 9S-13S.
8. Cohen J. Management of bacterial meningitis in adults. Br Med J 2003; 326: 996-997.
9. Johnson JL, Hirsch CS. Aspiration pneumonia: recognizing and managing a potentially growing disorder. Postgrad Med 2003; 113: 99-102.
10. Bernstein JM, Campbell GD. Treatment of pneumonia and its implications for antimicrobial resistance. Chest 1999; 115: 1S-2S.
11. Yates RR. New intervention strategies for reducing antibiotic resistance. Chest 1999; 115: 24S-27S.
12. Kunin CM, Lipton HL, Tupasi T, Sacks T, Scheckler WE, Jivani A. Social, behavioural and practical factors affecting antibiotic use world wide: report of task force 4. Rev Infect Dis 1987; 9 (Suppl. 3): 270-285.
13. Jarvis WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: the complexity of the problem. Infect Control Hosp Epidemio 1996; 17: 490-495.